Global Perspectives in Breast Cancer

Expert perspectives and strategic insights on the latest therapeutic developments in breast cancer.

April 28, 2021

Faculty Chair

Joyce O’Shaughnessy, MD

Texas Oncology, Dallas, TX

Faculty Members

Bill Gradishar, MD
Northwestern University Feinberg School of Medicine, Chicago, IL, USA

Peter Kaufman, MD

University of Vermont, Burlington, VT, US

Mark Pegram, MD
Stanford Women’s Cancer Center, Palo Alto, CA, US

Hope Rugo, MD, FASCO
University of California San Francisco Comprehensive Cancer Center, San Francisco, CA, US

Priyanka Sharma, MD
University of Kansas Medical Center, Kansas City,  KS, US

Sara Tolaney, MD, MPH
Dana-Farber Cancer Institute, Boston, MA, US

Sample Report

Start discovering the insights

View Report


The meeting report will be based on the following topics

  • Evolving Paradigms in HER2+ MBC
  • Individualizing Therapy for HER2+ Early Breast Cancer
  • Current and Investigational Approaches in Metastatic Triple-Negative Breast Cancer
  • Standard and Emerging Strategies for High-Risk Early Stage Triple-Negative Breast Cancer
  • Novel Targets in Breast Cancer
  • Evolving Treatments and New Developments in HR+ Metastatic Breast Cancer
  • Evolving Paradigms in HR+ Early Breast Cancer

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.